Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NDAC Member Resigns Over Plan B; Other Committees Discuss Departures

This article was originally published in The Tan Sheet

Executive Summary

Former Nonprescription Drugs Advisory Committee member Frank Davidoff, MD, no longer plans to advise other committee members to resign from their duties in protest of the agency's handling of the Barr Labs' Plan B switch application
Advertisement

Related Content

FDAer Resigns Over Plan B; Senators Seek Results Of GAO Investigation
FDA “Unable” To Decide On Plan B, Seeks Comment On Dual-Status Drugs
FDA “Unable” To Decide On Plan B, Seeks Comment On Dual-Status Drugs

Topics

Advertisement
UsernamePublicRestriction

Register

PS098714

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel